Yanguanjia Breath Analyzer HA Series

A range of diagnostic products based on breath analysis technology for various health conditions. The product line is designed for non-invasive disease screening and early detection.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.

A compact, battery-operated breath test device for quantitative measurement and display of hydrogen concentration in exhaled breath in ppm. The device measures breath gas values within standardized breath test procedures and displays them clearly on a readable display. It features intuitive touchscreen operation, integrated quality control routines, patient data management, continuous value history, semi-automatic calibration, and comes with PC software for Windows for data export via USB cable. The device is powered by four standard AA batteries and is supplied with a starter kit in a carrying case.

Breath test card for non-invasive diagnostic screening and monitoring of respiratory conditions. Single-use disposable device that captures and analyzes breath samples to detect biomarkers associated with various clinical conditions. Designed for point-of-care and laboratory settings with rapid turnaround results.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

Fractional exhaled nitric oxide (FeNO) measurement system for non-invasive assessment of airway inflammation. Utilized in diagnosis and monitoring of asthma, COPD, and chronic respiratory conditions with high-precision sensing technology.

In vitro diagnostic devices for breath testing applications. Supports various clinical assessments through non-invasive breath sample collection and analysis.

A breath analysis device used for smoking-related diagnostics. The device requires cleaning with alcohol-free solutions such as water, mild detergent, or approved cleaning compounds. It is part of Bedfont's range of breath analysis equipment for medical use.

A wearable device that performs laboratory-level analysis of biomarkers in breath samples in near-real-time. Based on headspace gas chromatography technology, it enables on-site measurement of metabolic markers including fat combustion indicators. Developed through 15+ years of research at ETH Zurich.